Oral medicine case book 49: plasmablastic lymphoma by Stander, Suzette et al.
184 >
case rePorT
A 25-year-old male patient presented at the Oral Medicine 
Clinic with a painful bleeding lesion on the palate causing him 
discomfort during speech, mastication, and sleep. The lesion 
started approximately five months earlier as a small growth 
that gradually increased in size. The patient was rather vague 
about his medical history and habits but he did reveal that 
he smoked two cigarettes per day as well as using cocaine, 
a habit for which he was receiving therapy, for drug-induced 
hallucinations, at a local psychiatric hospital. He was not 
aware of any other medical conditions or allergies. The extra-
oral examination revealed nothing of note, however, on intra-
oral examination a large and firm pedunculated exophytic soft 
tissue mass was seen on the hard palate. it covered a large 
portion of the hard palate extending from the back of the up-
per incisors posteriorly onto the anterior part of the soft palate 
and into the right vestibule. it extended laterally to the gingival 
margins of all the teeth in the first quadrant, resulting in an 
appearance of gingival hyperplasia. The growth had an ery-
thematous appearance with surface patches of necrosis and 
other areas that easily bled on touch (Figure 1).
 
Multiple punch biopsies of the lesion on the hard palate and 
buccal gingiva were performed and the specimens sent for 
histopathological investigation. The patient was dismissed with 
a supply of an antibacterial mouthwash consisting of a 0.2% 
aqueous solution of chlorhexidine digluconate, to be used twice 
daily to control superficial infection. He was requested to return a 
week later for suture removal and further management.
Diagnosis anD managemenT
The histopathological report revealed stratified squamous 
epithelial-lined fragments with an underlying diffuse pro-
liferation of large, atypical lymphoid cells. These large 
neoplastic cells showed plasmacytoid features with ve-
sicular nuclei, coarse chromatin and prominent nucleoli. 
The cytoplasm was basophilic to amphophilic in nature. 
Frequent mitoses and apoptotic cells were noted (Figure 
2). immunohistochemical staining was positive for CD38, 
a plasma cell marker (Figure 3). The proliferation index 
was very high (Figure 4) and the post germinal centre 
cell marker MUM-1, was positive (Figure 5). Staining for 
CD45, CD20 and CD3 were negative in tumour cells. The 
morphological and immunohistochemical features were 
consistent with a diagnosis of plasmablastic lymphoma.
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AIDS:  Acquired Immunodeficiency Syndrome   
EBER:  EBV-Encoded RNA    
EBV:  Epstein-Barr Virus   
HHV8:  human herpes Virus 8
HIV:  human Immunodeficiency Virus   
NH:  hodgkin’s Lymphoma     
NHL:  Non-hodgkin’s Lymphoma   
PBL:  Plasmablastic Lymphoma  
figure 1: This mirror view shows the exophytic pedunculated soft tissue 
growth and its erythematous surface with necrotic patches. The growth covers 
the entire hard palate and extends posteriorly to cover part of the soft palate, 
as well as extending into the right upper vestibule.
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At the succeeding appointment the histopathological report 
was discussed with the patient and he was referred to the 
Lymphoma Clinic at the nearby tertiary hospital for further man-
agement. The patient also received counselling before being 
referred for retroviral testing. The patient turned out to be HiV-
positive with a CD4 count of only 124. At the time of publication, 
the patient was on anti-retroviral medication, had completed his 
first course of chemotherapy and was doing reasonably well.
Discussion
Neoplasms arising from lymphoid tissue are generically re-
ferred to as lymphomas and are broadly divided into the 
Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma 
(NHL) groups. NHL is a heterogeneous group of malignant 
lymphomas distinguished from HL by the absence of the 
giant Reed-Sternberg cells that are characteristic of the 
latter. NHL is the more common type of lymphoma and is 
further divided into follicular and diffuse types. Plasmablas-
tic lymphoma (PBL) is a subtype of the diffuse large B-cell 
lymphoma. PBL was first described as recently as 1997 as 
a lymphoma presenting in the oral cavity of HiV-positive in-
dividuals. it was seen to consist mainly of large cells having 
the characteristics of differentiating plasma cells (plasma-
blasts), hence the term ‘plasmablastic lymphoma of the oral 
cavity’ was coined for this type of lymphoma. Subsequently, 
PBL was also described as occurring in other extranodal 
sites and in the 2008 World Health Organisation classifica-
tion of lymphomas the descriptive phrase “of the oral cavity” 
was dropped from the terminology. Although most reported 
cases are in fact seen in HiV-positive persons, it may also 
occur in other immunodeficiency states and PBL is thus not 
considered to be an AiDS-defining disease.1,2
PBL has a strong viral association especially in the pres-
ence of severe immunodeficiency such as that induced 
by HiV infection. The Epstein-Barr virus (EBV), the putative 
causative agent of infectious mononucleosis and Burkitt’s 
lymphoma, is known to infect B lymphocytes and convert 
them into immortal lymphoblasts. The presence of such 
infected cells results in the expression of latent gene prod-
ucts which may promote cell growth and impair apoptosis, 
thus leading to neoplastic transformation. The virus asso-
ciated with Kaposi’s sarcoma, the Human Herpes Virus 8 
(HHV8), may also be involved by its propensity to stimulate 
lymphomagenesis. Whereas it is thought that EBV plays an 
important aetiological role in PBL, it seems that the same 
role for HHV8 is still controversial.1,2,3 The role of smoking 
in the development of PBL is uncertain but it is thought to 
have a synergistic influence.
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figure 2: This haemotoxylin and eosin stained slide shows the histological 
features of plasmablastic lymphoma that consists of a diffuse proliferation of 
large cells resembling plasmablasts and immunoblasts.
figure 5: The immunohistochemical stain MUM-1 is positive in the atypical cells.
figure 3: The plasmablastic lymphoma cells are strongly and diffusely posi-
tive for Cd38
figure 4: The measured proliferative index is very high (Ki67 > 90%). 
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The mean age of patients with PBL is approximately 39 
years with a high male prevalence, however, the latter may 
be the result of the preponderance of males in the HiV-
positive population in developed countries.4.5 in the African 
setting, this gender trend may well be reversed due to a 
different profile of the HiV-positive persons in many African 
countries. PBL is most often seen in the oral cavity and has 
a rapidly progressive clinical course. Extra-oral sites affect-
ed by PBL include the lung, stomach, ano-rectal region, 
nasal cavity, maxillary sinuses, pharynx, bone, skin and 
other soft tissues. According to the literature, such extra-
oral PBL lesions are relatively rare, however, this may be 
due to the difficulty in correctly diagnosing these lesions in 
remote sites.6 Moreover, it appears that such lesions occur 
less commonly in immunocompromised persons than is the 
case with oral lesions.1 Lesions usually present as a local-
ised, painful and rapidly growing neoplastic mass, clinically 
similar to Kaposi’s sarcoma, and may infiltrate the adjacent 
bone.1,5 Thus an early and accurate diagnosis is essential 
and can only be achieved by histopathological evaluation, 
including appropriate immunohistochemical analysis.
The histopathological features of PBL is that of a cellular 
proliferation in the form of sheets of large lymphoid cells 
in a background of small mature lymphocytes and mac-
rophages.3,5,7 The neoplastic infiltrate typically invade the 
surrounding soft tissue and results in superficial ulceration 
and necrosis. The neoplastic cells show plasmablastic dif-
ferentiation in the form of round to oval shaped cells with 
eccentrically placed nuclei and with abundant eosinophilic 
cytoplasm.7, 2 Cells show a high mitotic rate and stain posi-
tive for the Ki-67 proliferation index, usually involving 90% 
of the tumour cells.3, 5 Mature lymphoid cells, occasional 
neutrophils and a few eosinophils may also be present.7 
PBL cells also stain positive for plasma cell markers such 
as CD38, CD138, Vs38c but not for the B-cell antigen, 
CD20.3 in addition, the detection of EBV by in situ hibridisa-
tion for EBER (EBV-encoded RNA) is helpful in confirming 
the diagnosis in approximately 60-75% of cases. in the oral 
cavity the rate of EBV infection is nearly 100%.8
The differential diagnosis for patients with a rapidly-growing 
oral lesion should include infectious and malignant condi-
tions. infectious lesions that should be considered are the 
relatively common odontogenic abscesses arising from in-
fection with typical oral flora. Malignant processes should 
include oral squamous cell carcinoma, metastatic tumours, 
Kaposi’s sarcoma, diffuse large B-cell lymphoma, plasma-
cytomas and Burkitt’s lymphoma.3
 
Management of individuals with PBL include chemotherapy 
or radiotherapy with or without surgical excision, or a combi-
nation of chemotherapy and radiotherapy depending on the 
stage of the tumour, the systemic symptoms and HiV co-
infection.3,9 The prognosis of PBL is poor and death usually 
occurs within 1 to 24 months after diagnosis.7
conclusion
The present case is a stark reminder that any growth in the 
oral cavity should be diagnosed as soon as possible in or-
der to get the patient properly managed in cases of life-
threatening conditions, such as PBL. it also demonstrates 
just how rapidly a large PBL lesion can develop and how 
aggressive these lesions can be. Moreover, it should be 
noted that PBL patients must be considered positive for HiV 
infection until proven otherwise. Although HiV-positivity had 
not been established in this patient at the time of diagnosis, 
it is highly probable that the patient would be positive for HiV. 
The patient’s habits of tobacco and drug use may have had 
an effect, however, the history obtained from the patient was 
so sketchy that no deduction could be made on the possi-
ble effect of these noxious habits. Due to the destructive be-
haviour and poor prognosis of PBL, especially if associated 
with AiDS, the early diagnosis of both these conditions will 
allow for appropriate treatment of PBL with chemotherapy, 
at the earliest possible moment, as well as allow prompt 
enrolment into a HiV treatment programme in the case of 
HiV-positive patients. Such measures will undoubtedly help 
to reduce the morbidity and mortality relating to PBL, and 
of other possible AiDS-related diseases, thus improving the 
patient’s survival rate and quality of life. Moreover, any oral 
mass, especially when occurring in immuno-compromised 
individuals, should be referred for biopsy.
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